-
“We have a team of world-class experts in data science and genomics and have developed a next-generation suite of risk prediction tools based around polygenic risk scores (PRS). As we …
-
“We needed an expert assessment of our clinical and commercial strategies from three different perspectives: regulators, payers, and physicians. MDisrupt helped us clearly define a go-to-market strategy that meet our …
-
“MDisrupt performed a benchmarking study for us. We found their work to be thorough and thoughtful. The recommendations they provided were relevant and insightful.”
4 more testimonials
currently locked